Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Carcinoma and FGF3[original query] |
---|
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment. Oncotarget 2016 Aug 7 (31): 49091-49098. Kaibori Masaki, Sakai Kazuko, Ishizaki Morihiko, Matsushima Hideyuki, De Velasco Marco A, Matsui Kosuke, Iida Hiroya, Kitade Hiroaki, Kwon A-Hon, Nagano Hiroaki, Wada Hiroshi, Haji Seiji, Tsukamoto Tadashi, Kanazawa Akishige, Takeda Yutaka, Takemura Shigekazu, Kubo Shoji, Nishio Kazu |
Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients. Oncotarget 2016 Mar . Li Fan, Xia Weiliang, Wang Guan, Tan Qiang, Li Ziming, Niu Xiaomin, Ji Wenxiang, Yuan Hong, Xu Qiang, Luo Qingquan, Zhang Jie, Lu Sh |
Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and therapy 2020 13 12797-12809. Zhang Nan, Shi Junping, Shi Xiaoliang, Chen Wenting, Liu Junfe |
The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody. Frontiers in immunology 2022 7 13 930096. Liu Chenxi, Zhu Sihui, Dong Yanbing, Shao Jie, Liu Baorui, Shen J |
Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients. Frontiers in molecular biosciences 2021 8 800679. Ke Lixin, Shen Jianming, Feng Jikun, Chen Jialin, Shen Shunli, Li Shaoqiang, Kuang Ming, Liang Lijian, Lu Cuncun, Li Dongming, He Qiang, Peng Baogang, Hua Yunpe |
Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. JAMA network open 2023 3 6 (3): e233329. Zhao Fangyuan, Miyashita Minoru, Hattori Masaya, Yoshimatsu Toshio, Howard Frederick, Kaneva Kristiyana, Jones Ryan, Bell Joshua S K, Fleming Gini F, Jaskowiak Nora, Nanda Rita, Zheng Yonglan, Huo Dezheng, Olopade Olufunmilayo |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: